AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe
... Results to Help Clinicians Improve Antibiotic selection
and Outcomes for Critical Infections
WOBURN, ... results by up to 48-72 hours, improved antibiotic selection
for patients with bloodstream infections, reduced ... them to make the most appropriate antibiotic selection
and treatment decision as early as possible," ...
Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
... of the following Kroger, Store-Brand and Private selection
store-baked and store-packaged cookies:
... Cookies - Regular and Jumbo
Peanut Chocolate Chunk Cookies
Gourmet Variety Cookie Trays
AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
... the PNA FISH test "can impact the
of the most effective antifungal therapy, ... provide more appropriate care, improve antifungal selection
hopefully improve outcomes for their ... Blood Cultures using PNA FISH Technology on selection
of Antifungal Therapy. Poster 1382. ECCMID ....
CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
to facilitate the medication selection
for patients with eating disorders
and comorbid ... that rEEG successfully guided physician selection
each patient's medications in the series, ... benefits of personalized medication selection
based on analysis of
brain physiology. It is not ...
Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
... in a
presentation titled "Combination Drug selection
Trial in Amyotrophic
Lateral Sclerosis" at the ... The primary objective of the trial was selection
of a treatment
based on which drug combination ... after the first pool of patients met the selection
"We are encouraged that the ...
InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
... - Results inform selection
of doses, regimens to be explored in Phase 2b study -
-- Phase 2b ... "The Phase 1b triple combination study was designed to inform the dose selection
and study design of the ITMN-191 Phase 2 program. The Phase 2b program ...
Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball
... that elbow ulnar collateral ligament (UCL) reconstruction prior to selection
in the Major League Baseball (MLB) draft does not increase the risk of ... the control group.
"Our data shows that UCL reconstruction prior to selection
in the MLB draft does not appear to increase the chances of a future ...
American Dairy Provides Business Update
... Joint Research Center of the World Business on January 1, 2009. The selection
committee evaluated more than 3,000 companies in Mainland China, Macau, Hong Kong and Taiwan based on the selection
criteria including popularity, reputation, credibility, satisfaction, ...
Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
CPR investigator database, provides a powerful dataset for site selection
"The clinical trials industry has ... (areas of low disease prevalence). This data-driven approach to
results in identification of the most qualified investigators,
leading to ...
Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
... embryos. These proteins may prove
to be biomarkers that can enhance selection
and result in more live births
from single embryo transfers. These are ... result in new
therapeutic strategies, diagnostic paradigms, and enhanced selection
single embryo transfers. These statements are based upon the ...
Exelixis Announces First Quarter 2008 Financial Results
... inhibitor of MEK, which is currently in a phase 1 clinical trial. selection
of the compound and opt-in by Genentech triggered a payment of $3.0 ... the hedgehog signaling pathway, for which we received a $20.0 million selection
milestone in February 2008. In addition, we exercised our option under ...
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
... highly anticipated new HIV drugs in development."
Trofile is a patient selection
co-receptor tropism assay that
determines whether a patient is infected ... our Trofile Assay, the potential use of our Trofile
Assay for patient selection
for the class of HIV drugs known as CCR5
antagonists, the size and timing ...
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
... of the gene of interest with an efficiency that
obviates the need for selection
markers and other complicated strategies to
identify knockout cells -- a ... that the disruption process occurred with
sufficiently high frequency that selection
markers were not required to
identify multiple independent knockout cell ...
Anti-Cancer Drug CYT997 Update
... States and the United Kingdom over an 18
month period. Overseas site selection
will be finalised within three
The study will also use advanced ... properties. Data from these
studies will assist the company in the selection
and design of later stage
The company will also ...
Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
... Transplant Center from
Jan. 1 through Dec. 31, 2005. A transplant selection
determines patient eligibility for liver transplant ... referral for liver transplant often undergo
repeated assessments by selection
committees, as their eligibility can
change over time or following ...
DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
... commercially available.
Trofile is a patient selection
co-receptor tropism assay that
determines whether a patient is infected ... for our Trofile
Assay, the potential use of our Trofile Assay for patient selection
class of HIV drugs known as CCR5 antagonists, the size and timing ...
Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting
... Analysis Points to Appropriate Patient selection
Criteria for Future Field Trial of TOLAMBA
... concomitant use of two
parameters of skin test positivity could enable the selection
with substantially increased levels of ragweed specific ...
Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
... segments of chromosomes or all genes or
exons. The study, entitled "Direct selection
of Human Genomic Loci by
Microarray Hybridization," appears online (ahead ... CM, Rodesch MJ, Packard CJ, Weinstock GM, and Gibbs RA.
2007. Direct selection
of human genomic loci by microarray hybridization.
Nat Meth. Published ...
Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
... Monogram's co-receptor tropism assay,
Trofile(TM), was used for patient selection
for Selzentry's clinical
development program, and is currently being ... and patients running low on
options. About Trofile Trofile is a patient selection
co-receptor tropism assay that
determines which co-receptor a patient's ...
Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
... stem cells in the adult human brain produce new brain tissue, including neurons. With its predictive screening platform, BCI can direct the selection
and development of neurogenic compounds, increasing the opportunity for successful clinical trials in a variety of indications. For more information, ...
Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
... for the second year of this grant. A rigorous review and evaluation of all the applications was provided by the U.S. Probiotics Scientific Board selection
Committee, which is comprised of W. Allan Walker, MD, Conrad Taff Professor of Nutrition at Harvard Medical School, Mary Ellen Sanders, PhD, ...
National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
... into the specific bio-marker (tumor glutathione levels) that increases the probability of achieving improved anti-tumor effectiveness by careful selection
of patients who are most likely to benefit, and is consistent with our focus on personalized approaches to cancer drug development," said Jack ...
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
... cells," stated Philip Gregory, D. Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection
markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and ...
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
... The Company
specialises in the strategic development, management and analysis of programs
that support clinical development - from compound selection
to Phase I-IV
clinical studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 71 locations in 38 countries and has ...
CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy
... of Women's & Children's Health at the University of New South Wales . The group determined that while absolute predictive criteria for the selection
of the best embryo for single-embryo transfer remain elusive, CRi's Oosight instrument provides a useful, non-invasive means to accurately measure ...
Neurocrine Biosciences Presents Elagolix Data
... bone risk would be a significant step forward in the treatment of endometriosis and other hormone dependent diseases. These safety results support selection
of the appropriate elagolix dose and regimen for the Phase III trials."
Neurocrine Biosciences also presented a preclinical study which was ...
Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
... Tuesday, June 16th during the BioPharma Session at 12:30 p.m. (local time)
at the David Intercontinental Hotel in Tel-Aviv, Israel.
of Oramed as one of the companies to present at the
ILSI-Biomed is a great opportunity that allows us to present our company to
the leading ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... were presented on 18 evaluable patients treated at doses of 1.0 - 1.88mg/kg from the Phase I portion and the initial portion of the Phase II study. selection
for enrollment was not based on expression of GPNMB in patients' tumors. The median number of prior chemotherapy regimens for metastatic disease was ...
Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
... patients with a variety of cancers as well as specifically those with colorectal and ovarian cancers. These additional data will guide our selection
of the most promising solid tumor indications for further study in Phase 2. The recent initiation of Phase 1 studies in multiple myeloma and leukemia ...
Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
... II colon cancer patients following surgery. The study, "A quantitative multi-gene RT-PCR assay for prediction of recurrence in stage II colon cancer: selection
of the genes in 4 large studies and results of the independent, prospectively-designed QUASAR validation study" (Abstract #4000), which was ...
Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
... also rank availability in intravenous formulation and a low propensity to induce resistance as other important drug attributes that influence their selection
in antibiotics," added Ms. Arias. "While some agents with anaerobic and gram negative activity, such as carbapenems, address some of these ...
Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
... mission of curing cancer at the earliest possible time."
Dream Teams Selected Through Rigorous and Transparent Process
The Dream Team selection
process began in July 2008 when AACR issued a call for research ideas. In response, Stand Up To Cancer received 237 submissions, representing ...
Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
... for the over 14 million patients in the United States and Europe who suffer from Peripheral Arterial Disease (PAD). These milestones include the selection
of physician investigators for U.S. clinical trials and the completion of a new state-of-the-art manufacturing facility.
New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
... should be initiated under close medical supervision and consideration given to use of a lower starting dose
For BENICAR HCT, dose selection
for an elderly patient should be cautious, usually starting at the low end of the dosage range
*Creatinine clearance <40 mL/min. ...
Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program
... N.Y.) is an emerging biotechnology company with a proprietary biopharmaceutical drug pipeline and platform technology for human monoclonal antibody selection
and affinity maturation. The company's contract division has developed over 150 recombinant proteins in multiple expression systems including 12 ...
Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
... in a preclinical model of prostate
cancer. Both antibodies were isolated using Affitech's unique MBAS (Molecule
Based Antibody Screening) method for selection
and improvement of fully human
antibodies from large libraries.
The researchers from Peregrine, Affitech and UT Southwestern Medical
Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
... for the full course of therapy with a single insertion of the DUROS device on day 1 and removal on day 29. Results of the phase 1 study will support selection
of doses to be evaluated in a controlled phase 2 study planned for later in 2009 in which longer durations of treatment with a single ITCA 650 ...
Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
... to the advanced form of AMD increased from about three-fold for nonsmokers to nearly 10-fold for smokers.
"Our algorithm could help with the selection
of study participants for treatment trials and could one day enable doctors to choose the most efficacious treatment for individual patients," Dr. ...
University of California Los Angeles Selects Velos eResearch
... (TORI). Plans are in place to deploy the system in non-cancer studies being conducted in the David Geffen School of Medicine at UCLA .
A UCLA selection
committee chose Velos eResearch because the system offered the best core functionality for managing clinical trials and it was the most adaptable and ...
Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
... - Tumor Biology 2, Abstract 145
Tuesday, April 21, 2009: 8:00 AM Quarfloxin phase I clinical data and scientific findings supporting the selection
of carcinoid/neuroendocrine tumors as the phase II indication - Clinical Research 12, Abstract 3599
Tuesday, April 21, 2009: 1:00 PM ...